Jump to content

LEAP-008 Clinical Trial


LUNGevityHunter

Recommended Posts

You may be able to join this study if you have metastatic NSCLC and were previously treated with platinum doublet chemotherapy and immunotherapy, but your cancer is getting worse

You have a 1 in 3 chance of being placed in each group.

Group 1 - You have 4 chances in 9 of being assigned to this group. People assigned to Group 1 will get pembrolizumab and lenvatinib.

Group 2 - You have 4 chances in 9 of being assigned to this group. People assigned to Group 2 will get docetaxel.

Group 3 - You have 1 chance in 9 of being assigned to this group. People assigned to Group 3 will get lenvatinib alone.

You, your trial doctor, and the trial staff will know what you are getting.

Visit  https://merckoncologyclinicaltrials.com/en-us/patient/trial/NCT03976375 or call 888-577-8839 for more information

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.